Head and neck cancer clinical trials are important research studies designed to evaluate the effectiveness of promising new therapies in comparison to the currently available options. The goal is to find better ways to treat cancer – and ultimately find a cure – while enhancing patient quality of life. All new treatment options are evaluated in this way; in fact, the current standard of care was once available only through clinical trials.
As a recognized leader in performing groundbreaking cancer research, Moffitt Cancer Center has a nationally acclaimed clinical trials program with active protocols for various types of head and neck cancer. For instance, our researchers are studying:
- New surgical techniques
- New radiation delivery methods
- New chemotherapy drugs, drug combinations and dosages
- Emerging treatments, such as gene therapy
- New ways to prevent cancer recurrence
Patients who take part in clinical trials can not only contribute to the existing knowledge base to help all current and future cancer patients, but also benefit personally by being closely monitored by a team of cancer experts as they receive either the current standard of care or new treatments that are unavailable elsewhere.
Patients who turn to Moffitt for head or neck cancer treatment can feel confident that they will receive the most effective treatment options available – whether or not they choose to participate in clinical trials. Our multispecialty team of experts emphasizes a bench-to-bedside approach, incorporating the latest laboratory findings into every patient’s unique treatment plan.
If you’d like to learn more about head and neck cancer clinical trials at Moffitt, call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online. No referrals are required.